COMPASS Pathways’s Crystalline Form Patent
Recently, Compass Pathways issued a press release stating “that it has been granted US Patent No 10,519,175 (“the ‘175 patent”), relating to methods of treating drug-resistant depression with a psilocybin …
Psychedelic Investment Opportunities – 2020 Perspective
Investing in psychedelics (e.g., magic mushrooms, psilocybin, etc.) has became a hot topic during 2019. Following Peter Thiel’s investment in Compass Pathway in 2018, several high-profile investors entered the psychedelic …
Has Yield Growth subsidiary Flourish Mushroom Labs revolutionized the field of psychedelics?
Yield Growth subsidiary Flourish Mushroom Labs appears to have discovered a fundamentally new use for the active compounds in magic mushrooms, i.e. psilocin and its prodrug psilocybin. On December 10, …
Coffee with Psilocybin?
Based on newfound benefits of magic mushrooms and the changing cultural (and legal) climate, some early movers have started working on psilocybin containing consumer products, like foods and beverages. On …
Wuhan Signs LOI with Biodelta One Month after Launching Psilocybin Division
On May 17, 2019, Wuhan General Group (“Wuhan”) announced signing a Letter of Intent (“LOI”) with Biodelta Nutraceuticals, Ltd. This announcement follows Wuhan’s April 5, 2019 announcement that its wholly-owned …
Compass Pathways’s Patents
In late April of 2019, both the United States Patent and Trademark Office (“USPTO”) and the World Intellectual Property Office (“WIPO”) published Compass Pathways’s Patent Applications directed to psilocybin technology. …
Investing in Psychedelics, Psilocybin, or Magic Mushrooms
** See also recent article on “Investing in Psychedelics – a 2020 Perspective” ** [Updated December 2019] Are magic mushrooms (or psilocybin) going to be the next big investment opportunity …
Arguments Against Magic Mushrooms or Psilocybin?
The scientific community universally agrees that psilocybin and/or magic mushrooms have enormous potential for treating some of the world’s biggest health problems. Furthermore, scientists agree that psychedelics (like magic mushrooms, …
$800 Million Valuation for First Psilocybin Company?
Recent developments in science and policy reform suggest that “magic mushrooms” and psilocybin technology will evolve into a psilocybin industry. Investments by several early movers illustrate that a psilocybin industry …
Psilacetin and Psilocybin — Two Equivalent Means for Administering Psilocin
The molecule Psilacetin (aka 4-AcO-DMT or O-Acetylpsilocin) is a synthetic psilocybin derivative. Like psilocybin, psilacetin serves as a prodrug of psilocin, which is the primary active molecule responsible for the …